[1] 中华口腔医学会口腔病理学专业委员会.口腔癌及口咽癌病理诊断规范[J].中华口腔医学杂志,2020,55(3):145-152. [2] Zumsteg ZS, Luu M, Rosenberg PS, et al. Global epidemiologic patterns of oropharyngeal cancer incidence trends [J]. J Natl Cancer Inst, 2023, 115(12):1544-1554. [3] Lechner M, Liu J, Masterson L, et al. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management [J]. Nat Rev Clin Oncol, 2022, 19(5):306-327. [4] 刘娅,周亚宁,左丹,等.口咽癌根治性调强放疗晚期不良反应研究进展[J].中华放射肿瘤学杂志,2024,33(5):461-465. [5] Berger BM, Hanna GJ, Posner MR, et al. Detection of occult recurrence using circulating tumor tissue modified viral HPV DNA among patients treated for HPV-driven oropharyngeal carcinoma [J]. Clin Cancer Res, 2022, 28(19):4292-4301. [6] 李晨曦,龚忠诚,周晓辉,等.老年头颈鳞癌患者的治疗现状[J].中华老年口腔医学杂志,2024,22(3):188-192. [7] 李晨曦,龚忠诚,赵化荣,等.周全性老年评估在老年头颈癌患者中的应用[J].口腔医学,2024,44(8): 630-634. [8] Li CX, Wang ZY, Tong QY, et al. Effect of prognostic factors of postoperative radiotherapy in oral squamous cell carcinoma: A SEER-based study [J]. Ear Nose Throat J, 2023:1455613231210388. [9] 李晨曦,冯计萍,孙家琳,等.代谢综合征患者发生甲状腺结节的风险评估及其诊断预测模型建立[J].国际耳鼻咽喉头颈外科杂志,2023,47(1): 6-12. [10] 李倩,李晨曦,方昌,等.基于SEER数据库1026例头颈部鳞状细胞癌患者的预后分析[J].口腔颌面外科杂志,2023,33(4):229-236. [11] 李晨曦,刘英,方昌,等.基于SEER数据库构建唾液腺腺样囊性癌患者预后分析模型[J].中国耳鼻咽喉头颈外科,2022,29(12):749-753. [12] 李晨曦,苏丽萍,龚忠诚,等.肉芽肿性多血管炎与头颈癌关联分析[J].中华风湿病学杂志,2023,27(12):793-798. [13] 尚伟,郑家伟. 2019年NCCN口腔口咽癌诊疗指南更新解读[J].中国口腔颌面外科杂志,2019,17(6):481-485. [14] Machczyski P, Majchrzak E, Niewinski P, et al. A review of the 8th edition of the AJCC staging system for oropharyngeal cancer according to HPV status [J]. Eur Arch Otorhinolaryngol, 2020, 277(9):2407-2412. [15] Hussein AA, Helder MN, de Visscher JG, et al. Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review [J]. Eur J Cancer, 2017, 82:115-127. [16] Hur JY, Ku BM, Park S, et al. Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma [J]. PLoS One, 2022, 17(10):e0274830. [17] Nguyen NP, Ly BH, Betz M, et al. Importance of age as a prognostic factor for tonsillar carcinoma [J]. Ann Surg Oncol, 2010, 17(10):2570-2577. [18] Conarty JP, Wieland A. The tumor-specific immune landscape in HPV+ head and neck cancer [J]. Viruses, 2023, 15(6):1296. [19] Perea LME, Antunes JLF, Peres MA. Oral and oropharyngeal cancer mortality in Brazil, 1983-2017: Age-period-cohort analysis [J]. Oral Dis, 2022, 28(1):97-107. [20] Li CX, Tan XR, Wei W, et al. A radiobiological perspective on radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma [J]. Rep Pract Oncol Radiother, 2024, 28(6):809-822. [21] Li CX, Gong ZC, Zhang WN, et al. Radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma: biological angle [J]. Oral Maxillofac Surg, 2024, 28(2):547-555. [22] Li CX, He Q, Wang ZY, et al. Risk assessment of venous thromboembolism in head and neck cancer patients and its establishment of a prediction model [J]. Head Neck, 2023, 45(10):2515-2524. [23] LeHew CW, Weatherspoon DJ, Peterson CE, et al. The health system and policy implications of changing epidemiology for oral cavity and oropharyngeal cancers in the united states From 1995 to 2016 [J]. Epidemiol Rev, 2017, 39(1):132-147. [24] Albert A, Giri S, Kanakamedala M, et al. Racial disparities in tumor features and outcomes of patients with squamous cell carcinoma of the tonsil [J]. Laryngoscope, 2019, 129(3):643-654. [25] Gormley M, Dudding T, Kachuri L, et al. Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization [J]. BMC Med, 2022, 20(1):40. [26] Wang W, Song C, Su Z, et al. Assessing the burden of HPV-related head and neck cancers in mainland China: protocol of a nationwide, multisite, cross-sectional study [J]. BMJ Open, 2023,13(11):e073277. [27] Li Y, Xu C. Human papillomavirus-related cancers [J]. Adv Exp Med Biol, 2017, 1018:23-34. |